Vladimir Vexler - Jan 10, 2023 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Chief Scientific Officer
Signature
/s/ McDavid Stilwell, as Attorney-in-Fact for Vladimir Vexler
Stock symbol
CHRS
Transactions as of
Jan 10, 2023
Transactions value $
-$72,436
Form type
4
Date filed
1/12/2023, 03:37 PM
Previous filing
Jan 6, 2023
Next filing
Jan 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Tax liability -$35.5K -3.6K -3.66% $9.85 94.9K Jan 10, 2023 Direct F1
transaction CHRS Common Stock Tax liability -$37K -3.6K -3.79% $10.26 91.3K Jan 11, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.